EDIT
Price
$3.15
Change
-$0.11 (-3.37%)
Updated
Jul 25 closing price
Capitalization
263.7M
4 days until earnings call
VCYT
Price
$25.25
Change
+$1.66 (+7.04%)
Updated
Jul 25 closing price
Capitalization
1.66B
11 days until earnings call
Interact to see
Advertisement

EDIT vs VCYT

Header iconEDIT vs VCYT Comparison
Open Charts EDIT vs VCYTBanner chart's image
Editas Medicine
Price$3.15
Change-$0.11 (-3.37%)
Volume$1.28M
Capitalization263.7M
Veracyte
Price$25.25
Change+$1.66 (+7.04%)
Volume$5.36M
Capitalization1.66B
EDIT vs VCYT Comparison Chart in %
Loading...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EDIT vs. VCYT commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDIT is a Hold and VCYT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (EDIT: $3.15 vs. VCYT: $25.25)
Brand notoriety: EDIT and VCYT are both not notable
EDIT represents the Biotechnology, while VCYT is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: EDIT: 49% vs. VCYT: 529%
Market capitalization -- EDIT: $263.7M vs. VCYT: $1.66B
EDIT [@Biotechnology] is valued at $263.7M. VCYT’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • EDIT’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, EDIT is a better buy in the long-term than VCYT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 4 TA indicator(s) are bullish while VCYT’s TA Score has 4 bullish TA indicator(s).

  • EDIT’s TA Score: 4 bullish, 4 bearish.
  • VCYT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VCYT is a better buy in the short-term than EDIT.

Price Growth

EDIT (@Biotechnology) experienced а +14.13% price change this week, while VCYT (@Medical Specialties) price change was +7.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.01%. For the same industry, the average monthly price growth was +4.92%, and the average quarterly price growth was -2.24%.

Reported Earning Dates

EDIT is expected to report earnings on Nov 10, 2025.

VCYT is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical Specialties (+3.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCYT($1.66B) has a higher market cap than EDIT($264M). EDIT YTD gains are higher at: 148.032 vs. VCYT (-36.237). VCYT has higher annual earnings (EBITDA): -49.41M vs. EDIT (-244.52M). EDIT (221M) and VCYT (216M) have equal amount of cash in the bank . VCYT has less debt than EDIT: VCYT (12.6M) vs EDIT (31.1M). VCYT has higher revenues than EDIT: VCYT (361M) vs EDIT (35.8M).
EDITVCYTEDIT / VCYT
Capitalization264M1.66B16%
EBITDA-244.52M-49.41M495%
Gain YTD148.032-36.237-409%
P/E RatioN/AN/A-
Revenue35.8M361M10%
Total Cash221M216M102%
Total Debt31.1M12.6M247%
FUNDAMENTALS RATINGS
EDIT vs VCYT: Fundamental Ratings
EDIT
VCYT
OUTLOOK RATING
1..100
8174
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
77
Overvalued
PROFIT vs RISK RATING
1..100
10098
SMR RATING
1..100
9986
PRICE GROWTH RATING
1..100
3565
P/E GROWTH RATING
1..100
10093
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EDIT's Valuation (44) in the Biotechnology industry is somewhat better than the same rating for VCYT (77). This means that EDIT’s stock grew somewhat faster than VCYT’s over the last 12 months.

VCYT's Profit vs Risk Rating (98) in the Biotechnology industry is in the same range as EDIT (100). This means that VCYT’s stock grew similarly to EDIT’s over the last 12 months.

VCYT's SMR Rating (86) in the Biotechnology industry is in the same range as EDIT (99). This means that VCYT’s stock grew similarly to EDIT’s over the last 12 months.

EDIT's Price Growth Rating (35) in the Biotechnology industry is in the same range as VCYT (65). This means that EDIT’s stock grew similarly to VCYT’s over the last 12 months.

VCYT's P/E Growth Rating (93) in the Biotechnology industry is in the same range as EDIT (100). This means that VCYT’s stock grew similarly to EDIT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EDITVCYT
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
73%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 9 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LAVVX16.670.17
+1.03%
Lord Abbett Fundamental Equity R6
FRMPX27.610.27
+0.99%
Nuveen Small Cap Growth Opp A
MCMVX21.040.14
+0.67%
Monongahela All Cap Value
OGLNX98.720.29
+0.29%
Invesco Global R
PIIQX13.28-0.01
-0.08%
Principal International Equity Index R5